Loading…
Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors
Previous studies have reported that a high neutrophil-to-lymphocyte ratio (NLR) is associated with disease severity and poor prognosis in COVID-19 patients. We aimed to investigate the clinical implications of NLR in patients with COVID-19 complicated with cardiovascular diseases and/or its risk fac...
Saved in:
Published in: | Scientific reports 2022-08, Vol.12 (1), p.13606-13606, Article 13606 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c517t-b0976ad0c9969076d925e7b8fc755d0e5f94c1360e72c948ef1f84d303070ce63 |
---|---|
cites | cdi_FETCH-LOGICAL-c517t-b0976ad0c9969076d925e7b8fc755d0e5f94c1360e72c948ef1f84d303070ce63 |
container_end_page | 13606 |
container_issue | 1 |
container_start_page | 13606 |
container_title | Scientific reports |
container_volume | 12 |
creator | Higaki, Akinori Okayama, Hideki Homma, Yoshito Sano, Takahide Kitai, Takeshi Yonetsu, Taishi Torii, Sho Kohsaka, Shun Kuroda, Shunsuke Node, Koichi Matsue, Yuya Matsumoto, Shingo |
description | Previous studies have reported that a high neutrophil-to-lymphocyte ratio (NLR) is associated with disease severity and poor prognosis in COVID-19 patients. We aimed to investigate the clinical implications of NLR in patients with COVID-19 complicated with cardiovascular diseases and/or its risk factors (CVDRF). In total, 601 patients with known NLR values were selected from the CLAVIS-COVID registry for analysis. Patients were categorized into quartiles (Q1, Q2, Q3, and Q4) according to baseline NLR values, and demographic and clinical parameters were compared between the groups. Survival analysis was conducted using the Kaplan–Meier method. The diagnostic performance of the baseline and follow-up NLR values was tested using receiver operating characteristic (ROC) curve analysis. Finally, two-dimensional mapping of patient characteristics was conducted using t-stochastic neighborhood embedding (t-SNE). In-hospital mortality significantly increased with an increase in the baseline NLR quartile (Q1 6.3%, Q2 11.0%, Q3 20.5%; and Q4, 26.6%; p |
doi_str_mv | 10.1038/s41598-022-17567-4 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_68fb4951e1314a5aa7c710076ea02d2e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_68fb4951e1314a5aa7c710076ea02d2e</doaj_id><sourcerecordid>2700451810</sourcerecordid><originalsourceid>FETCH-LOGICAL-c517t-b0976ad0c9969076d925e7b8fc755d0e5f94c1360e72c948ef1f84d303070ce63</originalsourceid><addsrcrecordid>eNp9ks2OFCEUhStG40zaeQFXJG7clMNvUWxMTPvXySTjQt0SGm5109JFCVSbfhDfV3p6oo4L2UDgnI_L5TTNc4JfEcz668yJUH2LKW2JFJ1s-aPmkmIuWsooffzX-qK5ynmH6xBUcaKeNhdMKN53WF42Pz8lcN4WfwB0MGEGFAc0wlxSnLY-tCW24bifttEeC6Bkio9oiAmVLaDBFBN8OZ4sy9uvq7ctUWiqEhhLRjbup-CtKeDQD1-2yJrkfDyYbOdgEnI-g8mQkRnddSUmn79VpC0x5WfNk8GEDFf386L58v7d5-XH9ub2w2r55qa1gsjSrrGSnXHYKtUpLDunqAC57gcrhXAYxKC4JazDIKmtL4aBDD13DDMssYWOLZrVmeui2ekp-b1JRx2N13cbMW20ScXbALrrhzVXggBhhBthjLSS4HopGEwdhcp6fWZN83oPztYmJBMeQB-ejH6rN_GgFes4w7wCXt4DUvw-Qy5677OFEMwIcc6aSkywrGJVpS_-ke7inMbaqpOqfjzpa0gWDT2rbIo5Jxh-F0OwPoVIn0Oka4j0XYj0qQp2NuUqHjeQ_qD_4_oFp47KTA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2700451810</pqid></control><display><type>article</type><title>Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors</title><source>Open Access: PubMed Central</source><source>Full-Text Journals in Chemistry (Open access)</source><source>ProQuest - Publicly Available Content Database</source><source>Coronavirus Research Database</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Higaki, Akinori ; Okayama, Hideki ; Homma, Yoshito ; Sano, Takahide ; Kitai, Takeshi ; Yonetsu, Taishi ; Torii, Sho ; Kohsaka, Shun ; Kuroda, Shunsuke ; Node, Koichi ; Matsue, Yuya ; Matsumoto, Shingo</creator><creatorcontrib>Higaki, Akinori ; Okayama, Hideki ; Homma, Yoshito ; Sano, Takahide ; Kitai, Takeshi ; Yonetsu, Taishi ; Torii, Sho ; Kohsaka, Shun ; Kuroda, Shunsuke ; Node, Koichi ; Matsue, Yuya ; Matsumoto, Shingo</creatorcontrib><description>Previous studies have reported that a high neutrophil-to-lymphocyte ratio (NLR) is associated with disease severity and poor prognosis in COVID-19 patients. We aimed to investigate the clinical implications of NLR in patients with COVID-19 complicated with cardiovascular diseases and/or its risk factors (CVDRF). In total, 601 patients with known NLR values were selected from the CLAVIS-COVID registry for analysis. Patients were categorized into quartiles (Q1, Q2, Q3, and Q4) according to baseline NLR values, and demographic and clinical parameters were compared between the groups. Survival analysis was conducted using the Kaplan–Meier method. The diagnostic performance of the baseline and follow-up NLR values was tested using receiver operating characteristic (ROC) curve analysis. Finally, two-dimensional mapping of patient characteristics was conducted using t-stochastic neighborhood embedding (t-SNE). In-hospital mortality significantly increased with an increase in the baseline NLR quartile (Q1 6.3%, Q2 11.0%, Q3 20.5%; and Q4, 26.6%; p < 0.001). The cumulative mortality increased as the quartile of the baseline NLR increased. The paired log-rank test revealed significant differences in survival for Q1 vs. Q3 (p = 0.017), Q1 vs. Q4 (p < 0.001), Q2 vs. Q3 (p = 0.034), and Q2 vs. Q4 (p < 0.001). However, baseline NLR was not identified as an independent prognostic factor using a multivariate Cox proportional hazards regression model. The area under the curve for predicting in-hospital death based on baseline NLR was only 0.682, whereas that of follow-up NLR was 0.893. The two-dimensional patient map with t-SNE showed a cluster characterized by high mortality with high NLR at follow-up, but these did not necessarily overlap with the population with high NLR at baseline. NLR may have prognostic implications in hospitalized COVID-19 patients with CVDRF, but its significance depends on the timing of data collection.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-022-17567-4</identifier><identifier>PMID: 35948607</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/250/255/2514 ; 692/4019/592/75 ; 692/499 ; Cardiovascular diseases ; Coronaviruses ; COVID-19 ; Data collection ; Embedding ; Humanities and Social Sciences ; Leukocytes (neutrophilic) ; Lymphocytes ; Medical prognosis ; Mortality ; multidisciplinary ; Neutrophils ; Patients ; Risk factors ; Science ; Science (multidisciplinary) ; Survival analysis</subject><ispartof>Scientific reports, 2022-08, Vol.12 (1), p.13606-13606, Article 13606</ispartof><rights>The Author(s) 2022</rights><rights>The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c517t-b0976ad0c9969076d925e7b8fc755d0e5f94c1360e72c948ef1f84d303070ce63</citedby><cites>FETCH-LOGICAL-c517t-b0976ad0c9969076d925e7b8fc755d0e5f94c1360e72c948ef1f84d303070ce63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2700451810?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2700451810?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,25734,27905,27906,36993,36994,38497,43876,44571,53772,53774,74161,74875</link.rule.ids></links><search><creatorcontrib>Higaki, Akinori</creatorcontrib><creatorcontrib>Okayama, Hideki</creatorcontrib><creatorcontrib>Homma, Yoshito</creatorcontrib><creatorcontrib>Sano, Takahide</creatorcontrib><creatorcontrib>Kitai, Takeshi</creatorcontrib><creatorcontrib>Yonetsu, Taishi</creatorcontrib><creatorcontrib>Torii, Sho</creatorcontrib><creatorcontrib>Kohsaka, Shun</creatorcontrib><creatorcontrib>Kuroda, Shunsuke</creatorcontrib><creatorcontrib>Node, Koichi</creatorcontrib><creatorcontrib>Matsue, Yuya</creatorcontrib><creatorcontrib>Matsumoto, Shingo</creatorcontrib><title>Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><description>Previous studies have reported that a high neutrophil-to-lymphocyte ratio (NLR) is associated with disease severity and poor prognosis in COVID-19 patients. We aimed to investigate the clinical implications of NLR in patients with COVID-19 complicated with cardiovascular diseases and/or its risk factors (CVDRF). In total, 601 patients with known NLR values were selected from the CLAVIS-COVID registry for analysis. Patients were categorized into quartiles (Q1, Q2, Q3, and Q4) according to baseline NLR values, and demographic and clinical parameters were compared between the groups. Survival analysis was conducted using the Kaplan–Meier method. The diagnostic performance of the baseline and follow-up NLR values was tested using receiver operating characteristic (ROC) curve analysis. Finally, two-dimensional mapping of patient characteristics was conducted using t-stochastic neighborhood embedding (t-SNE). In-hospital mortality significantly increased with an increase in the baseline NLR quartile (Q1 6.3%, Q2 11.0%, Q3 20.5%; and Q4, 26.6%; p < 0.001). The cumulative mortality increased as the quartile of the baseline NLR increased. The paired log-rank test revealed significant differences in survival for Q1 vs. Q3 (p = 0.017), Q1 vs. Q4 (p < 0.001), Q2 vs. Q3 (p = 0.034), and Q2 vs. Q4 (p < 0.001). However, baseline NLR was not identified as an independent prognostic factor using a multivariate Cox proportional hazards regression model. The area under the curve for predicting in-hospital death based on baseline NLR was only 0.682, whereas that of follow-up NLR was 0.893. The two-dimensional patient map with t-SNE showed a cluster characterized by high mortality with high NLR at follow-up, but these did not necessarily overlap with the population with high NLR at baseline. NLR may have prognostic implications in hospitalized COVID-19 patients with CVDRF, but its significance depends on the timing of data collection.</description><subject>631/250/255/2514</subject><subject>692/4019/592/75</subject><subject>692/499</subject><subject>Cardiovascular diseases</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Data collection</subject><subject>Embedding</subject><subject>Humanities and Social Sciences</subject><subject>Leukocytes (neutrophilic)</subject><subject>Lymphocytes</subject><subject>Medical prognosis</subject><subject>Mortality</subject><subject>multidisciplinary</subject><subject>Neutrophils</subject><subject>Patients</subject><subject>Risk factors</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Survival analysis</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9ks2OFCEUhStG40zaeQFXJG7clMNvUWxMTPvXySTjQt0SGm5109JFCVSbfhDfV3p6oo4L2UDgnI_L5TTNc4JfEcz668yJUH2LKW2JFJ1s-aPmkmIuWsooffzX-qK5ynmH6xBUcaKeNhdMKN53WF42Pz8lcN4WfwB0MGEGFAc0wlxSnLY-tCW24bifttEeC6Bkio9oiAmVLaDBFBN8OZ4sy9uvq7ctUWiqEhhLRjbup-CtKeDQD1-2yJrkfDyYbOdgEnI-g8mQkRnddSUmn79VpC0x5WfNk8GEDFf386L58v7d5-XH9ub2w2r55qa1gsjSrrGSnXHYKtUpLDunqAC57gcrhXAYxKC4JazDIKmtL4aBDD13DDMssYWOLZrVmeui2ekp-b1JRx2N13cbMW20ScXbALrrhzVXggBhhBthjLSS4HopGEwdhcp6fWZN83oPztYmJBMeQB-ejH6rN_GgFes4w7wCXt4DUvw-Qy5677OFEMwIcc6aSkywrGJVpS_-ke7inMbaqpOqfjzpa0gWDT2rbIo5Jxh-F0OwPoVIn0Oka4j0XYj0qQp2NuUqHjeQ_qD_4_oFp47KTA</recordid><startdate>20220810</startdate><enddate>20220810</enddate><creator>Higaki, Akinori</creator><creator>Okayama, Hideki</creator><creator>Homma, Yoshito</creator><creator>Sano, Takahide</creator><creator>Kitai, Takeshi</creator><creator>Yonetsu, Taishi</creator><creator>Torii, Sho</creator><creator>Kohsaka, Shun</creator><creator>Kuroda, Shunsuke</creator><creator>Node, Koichi</creator><creator>Matsue, Yuya</creator><creator>Matsumoto, Shingo</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Portfolio</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220810</creationdate><title>Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors</title><author>Higaki, Akinori ; Okayama, Hideki ; Homma, Yoshito ; Sano, Takahide ; Kitai, Takeshi ; Yonetsu, Taishi ; Torii, Sho ; Kohsaka, Shun ; Kuroda, Shunsuke ; Node, Koichi ; Matsue, Yuya ; Matsumoto, Shingo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c517t-b0976ad0c9969076d925e7b8fc755d0e5f94c1360e72c948ef1f84d303070ce63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>631/250/255/2514</topic><topic>692/4019/592/75</topic><topic>692/499</topic><topic>Cardiovascular diseases</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Data collection</topic><topic>Embedding</topic><topic>Humanities and Social Sciences</topic><topic>Leukocytes (neutrophilic)</topic><topic>Lymphocytes</topic><topic>Medical prognosis</topic><topic>Mortality</topic><topic>multidisciplinary</topic><topic>Neutrophils</topic><topic>Patients</topic><topic>Risk factors</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Survival analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Higaki, Akinori</creatorcontrib><creatorcontrib>Okayama, Hideki</creatorcontrib><creatorcontrib>Homma, Yoshito</creatorcontrib><creatorcontrib>Sano, Takahide</creatorcontrib><creatorcontrib>Kitai, Takeshi</creatorcontrib><creatorcontrib>Yonetsu, Taishi</creatorcontrib><creatorcontrib>Torii, Sho</creatorcontrib><creatorcontrib>Kohsaka, Shun</creatorcontrib><creatorcontrib>Kuroda, Shunsuke</creatorcontrib><creatorcontrib>Node, Koichi</creatorcontrib><creatorcontrib>Matsue, Yuya</creatorcontrib><creatorcontrib>Matsumoto, Shingo</creatorcontrib><collection>SpringerOpen</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Higaki, Akinori</au><au>Okayama, Hideki</au><au>Homma, Yoshito</au><au>Sano, Takahide</au><au>Kitai, Takeshi</au><au>Yonetsu, Taishi</au><au>Torii, Sho</au><au>Kohsaka, Shun</au><au>Kuroda, Shunsuke</au><au>Node, Koichi</au><au>Matsue, Yuya</au><au>Matsumoto, Shingo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><date>2022-08-10</date><risdate>2022</risdate><volume>12</volume><issue>1</issue><spage>13606</spage><epage>13606</epage><pages>13606-13606</pages><artnum>13606</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Previous studies have reported that a high neutrophil-to-lymphocyte ratio (NLR) is associated with disease severity and poor prognosis in COVID-19 patients. We aimed to investigate the clinical implications of NLR in patients with COVID-19 complicated with cardiovascular diseases and/or its risk factors (CVDRF). In total, 601 patients with known NLR values were selected from the CLAVIS-COVID registry for analysis. Patients were categorized into quartiles (Q1, Q2, Q3, and Q4) according to baseline NLR values, and demographic and clinical parameters were compared between the groups. Survival analysis was conducted using the Kaplan–Meier method. The diagnostic performance of the baseline and follow-up NLR values was tested using receiver operating characteristic (ROC) curve analysis. Finally, two-dimensional mapping of patient characteristics was conducted using t-stochastic neighborhood embedding (t-SNE). In-hospital mortality significantly increased with an increase in the baseline NLR quartile (Q1 6.3%, Q2 11.0%, Q3 20.5%; and Q4, 26.6%; p < 0.001). The cumulative mortality increased as the quartile of the baseline NLR increased. The paired log-rank test revealed significant differences in survival for Q1 vs. Q3 (p = 0.017), Q1 vs. Q4 (p < 0.001), Q2 vs. Q3 (p = 0.034), and Q2 vs. Q4 (p < 0.001). However, baseline NLR was not identified as an independent prognostic factor using a multivariate Cox proportional hazards regression model. The area under the curve for predicting in-hospital death based on baseline NLR was only 0.682, whereas that of follow-up NLR was 0.893. The two-dimensional patient map with t-SNE showed a cluster characterized by high mortality with high NLR at follow-up, but these did not necessarily overlap with the population with high NLR at baseline. NLR may have prognostic implications in hospitalized COVID-19 patients with CVDRF, but its significance depends on the timing of data collection.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>35948607</pmid><doi>10.1038/s41598-022-17567-4</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2045-2322 |
ispartof | Scientific reports, 2022-08, Vol.12 (1), p.13606-13606, Article 13606 |
issn | 2045-2322 2045-2322 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_68fb4951e1314a5aa7c710076ea02d2e |
source | Open Access: PubMed Central; Full-Text Journals in Chemistry (Open access); ProQuest - Publicly Available Content Database; Coronavirus Research Database; Springer Nature - nature.com Journals - Fully Open Access |
subjects | 631/250/255/2514 692/4019/592/75 692/499 Cardiovascular diseases Coronaviruses COVID-19 Data collection Embedding Humanities and Social Sciences Leukocytes (neutrophilic) Lymphocytes Medical prognosis Mortality multidisciplinary Neutrophils Patients Risk factors Science Science (multidisciplinary) Survival analysis |
title | Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T13%3A22%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictive%20value%20of%20neutrophil-to-lymphocyte%20ratio%20for%20the%20fatality%20of%20COVID-19%20patients%20complicated%20with%20cardiovascular%20diseases%20and/or%20risk%20factors&rft.jtitle=Scientific%20reports&rft.au=Higaki,%20Akinori&rft.date=2022-08-10&rft.volume=12&rft.issue=1&rft.spage=13606&rft.epage=13606&rft.pages=13606-13606&rft.artnum=13606&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-022-17567-4&rft_dat=%3Cproquest_doaj_%3E2700451810%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c517t-b0976ad0c9969076d925e7b8fc755d0e5f94c1360e72c948ef1f84d303070ce63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2700451810&rft_id=info:pmid/35948607&rfr_iscdi=true |